RE: Happy new year everyone.2 Jan 2026 17:47
This was the last comments from the CEO at the bottom of the business update.
I'm not a fan of companies going on about 2025 when were only interested in the future and shareholder value.
He does have a good board of directors on paper but the CEO is full of hot air most of the time. I call him Peter Pan.
Nigel Theobald, Chief Executive Officer of N4 Pharma, commented:
"We are very encouraged by the progress being made across the Nuvec® programme and by the data emerging from our collaboration with the University of Strathclyde. The stability, targeting and oral delivery data generated to date reinforce our belief that Nuvec® has the potential to address several of the key limitations associated with lipid nanoparticles, which remain the current industry standard.
"N4 Pharma is building a robust, high-quality data package to support future commercial discussions. With multiple important readouts expected in the coming months, we believe Nuvec® continues to demonstrate its potential as a differentiated and commercially attractive delivery platform for RNA therapeutics and will provide the Company further opportunities to look at developing its own RNA assets in the future."